Nutriband Inc. (NTRB) Financial Ratios
11 years of historical data (2015–2025) · Healthcare · Biotechnology
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
6.61
+5% vs avg
5yr avg: 6.27
30Y Low2.5·High13.7
ROE
↓
-125.6%
↑-26% vs avg
5yr avg: -99.5%
30Y Low-264%·High-47%
Debt/EBITDA
N/A
—
5yr avg: N/A
30Y Low2.4·High2.4
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
NTRB Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Nutriband Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $46M | $56M | $88M | $21M | $31M | $30M | — | — | — | — | — |
| Enterprise Value | $42M | $51M | $84M | $21M | $29M | $25M | — | — | — | — | — |
| P/E Ratio → | -1.47 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 22.66 | 27.38 | 41.09 | 9.96 | 14.85 | 20.92 | — | — | — | — | — |
| P/B Ratio | 6.61 | 8.35 | 13.68 | 3.22 | 3.60 | 2.51 | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
NTRB EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 25.24 | 39.16 | 9.83 | 13.98 | 17.57 | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
NTRB Profitability
Margins and return-on-capital ratios measuring operating efficiency
Nutriband Inc. earns an operating margin of -408.4%. Operating margins have compressed from -233.6% to -408.4% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -125.6% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 25.7% | 25.7% | 32.7% | 41.3% | 36.1% | 35.5% | 38.3% | -48.1% | -17.5% | — | — |
| Operating Margin | -408.4% | -408.4% | -312.6% | -233.6% | -199.5% | -276.3% | -275.1% | -531.4% | -1358.1% | — | — |
| Net Profit Margin | -404.1% | -404.1% | -489.9% | -263.0% | -231.3% | -592.2% | -340.5% | -754.1% | -1358.1% | — | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -125.6% | -125.6% | -162.9% | -73.1% | -47.1% | -88.8% | -88.2% | -216.7% | -263.7% | -3695.2% | -2599.2% |
| ROA | -109.6% | -109.6% | -139.9% | -64.6% | -43.3% | -74.3% | -53.0% | -111.7% | -224.1% | -2637.3% | -794.9% |
| ROIC | -270.2% | -270.2% | -118.2% | -56.4% | -44.8% | -37.2% | -42.2% | -120.2% | -235.4% | -162.2% | -4136.6% |
| ROCE | -125.5% | -125.5% | -102.9% | -64.0% | -40.1% | -40.7% | -68.9% | -152.7% | -263.7% | -237.8% | -2454.5% |
NTRB Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
The company holds a net cash position — cash of $5M exceeds total debt of $209629, providing substantial financial flexibility for buybacks, acquisitions, or weathering downturns.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.03 | 0.03 | 0.04 | 0.02 | 0.01 | 0.25 | 1.83 | 0.02 | 0.26 | 0.45 |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.65 | -0.64 | -0.04 | -0.21 | -0.40 | 0.23 | 1.78 | -0.18 | 0.26 | -0.72 |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -369.11 | -369.11 | -488.67 | -71.35 | -539.89 | -51.15 | -9.45 | -36.07 | — | — | — |
Net cash position: cash ($5M) exceeds total debt ($209629)
NTRB Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Nutriband Inc.'s current ratio of 6.36x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The current ratio has improved from 1.02x to 6.36x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.36 | 6.36 | 4.88 | 1.02 | 3.60 | 7.01 | 0.12 | 0.02 | 1.47 | 3.80 | 2.58 |
| Quick Ratio | 6.21 | 6.21 | 4.66 | 0.85 | 3.29 | 6.84 | 0.10 | 0.02 | 1.47 | 3.71 | 2.03 |
| Cash Ratio | 5.83 | 5.83 | 4.39 | 0.49 | 2.65 | 6.28 | 0.06 | 0.01 | 1.18 | — | 1.86 |
| Asset Turnover | — | 0.27 | 0.29 | 0.28 | 0.22 | 0.11 | 0.10 | 0.17 | 0.09 | — | — |
| Inventory Turnover | 12.83 | 12.83 | 6.79 | 7.25 | 5.80 | 6.97 | 11.02 | 999999.00 | — | — | — |
| Days Sales Outstanding | — | 21.22 | 12.60 | 26.02 | 19.84 | 18.32 | 42.29 | 12.64 | 19.48 | — | — |
NTRB Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Nutriband Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | 0.7% | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.2% | 0.0% | 0.4% | 0.4% | — | — | — | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.2% | 0.0% | 0.4% | 1.0% | — | — | — | — | — |
| Shares Outstanding | — | $12M | $11M | $8M | $8M | $8M | $7M | $6M | $6M | $6M | $6M |
Peer Comparison
Compare NTRB with 9 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 NTRBYou | $46M | -1.5 | — | — | 25.7% | -408.4% | -125.6% | -270.2% | — |
 DARE | $25M | -6.1 | — | 5.3 | -146110.2% | -239692.2% | — | — | — |
 AVDL | $2B | -42.4 | — | — | 91.0% | -25.1% | -60.4% | -76.3% | — |
 MTUS | $765M | -640.6 | 10.8 | — | 8.2% | 0.1% | -0.2% | 0.2% | 0.3 |
 CLRB | $14M | -0.4 | — | — | — | — | -180.0% | — | — |
 PRGO | $2B | -1.1 | 7.4 | 11.1 | 35.1% | 8.1% | -39.3% | 3.7% | 5.8 |
 LPCN | $13M | -1.4 | — | — | -334.3% | -524.7% | -54.3% | -64.7% | — |
 NKTR | $2B | -8.6 | — | — | 100.0% | -236.8% | -217.9% | -57.2% | — |
 HALO | $8B | 25.5 | 8.3 | 11.9 | 78.1% | 58.4% | 153.6% | 73.4% | — |
 COLL | $1B | 22.7 | 4.8 | 3.9 | 59.3% | 24.0% | 23.7% | 14.0% | 2.3 |
| Healthcare Median | — | 22.3 | 14.4 | 18.5 | 63.9% | -5.2% | -33.7% | -11.2% | 3.3 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 11 years · Updated daily
See NTRB's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NTRB Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NTRB vs DARE
Side-by-side business, growth, and profitability comparison vs Daré Bioscience, Inc..
Start ComparisonNTRB — Frequently Asked Questions
Quick answers to the most common questions about buying NTRB stock.
What is Nutriband Inc.'s P/E ratio?
Nutriband Inc.'s current P/E ratio is -1.5x. This places it at the 50th percentile of its historical range.
What is Nutriband Inc.'s ROE?
Nutriband Inc.'s return on equity (ROE) is -125.6%. The historical average is -133.3%.
Is NTRB stock overvalued?
Based on historical data, Nutriband Inc. is trading at a P/E of -1.5x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Nutriband Inc.'s profit margins?
Nutriband Inc. has 25.7% gross margin and -408.4% operating margin.